XML 79 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
3 Months Ended 6 Months Ended
Jan. 01, 2018
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Mar. 31, 2018
Dec. 31, 2017
Property, Plant and Equipment [Line Items]              
Unrealized gain (loss) on equity method investments       $ 0 $ 24    
Total revenue   $ 90,043 $ 27,995 146,200 57,264    
Decrease in accumulated deficit   (254,240)   (254,240)     $ (400,924)
Operating income (loss)   70,175 13,015 107,216 23,233    
Milestone payment received       4,600      
Third-party in-licensor portion of milestone payment received       3,000      
Revenue recognized from milestone method revenue       1,600      
Gain (loss) from Viking   39,963 (1,400) 61,808 (2,406)    
Assets, fair value   877,560   877,560     188,764
Investment in Warrants              
Property, Plant and Equipment [Line Items]              
Assets, fair value   12,296   12,296     3,846
Note Receivable - Viking Therapeutics              
Property, Plant and Equipment [Line Items]              
Assets, fair value   0   0     3,877
Level 1              
Property, Plant and Equipment [Line Items]              
Assets, fair value   73,689   73,689     5,742
Level 1 | Investment in Warrants              
Property, Plant and Equipment [Line Items]              
Assets, fair value   12,296   12,296     3,846
Level 1 | Note Receivable - Viking Therapeutics              
Property, Plant and Equipment [Line Items]              
Assets, fair value   0   0     0
Level 3              
Property, Plant and Equipment [Line Items]              
Assets, fair value   0   0     3,877
Level 3 | Investment in Warrants              
Property, Plant and Equipment [Line Items]              
Assets, fair value   0   0     0
Level 3 | Note Receivable - Viking Therapeutics              
Property, Plant and Equipment [Line Items]              
Assets, fair value   0   0     3,877
Viking Therapeutics, Inc.              
Property, Plant and Equipment [Line Items]              
Unrealized gain (loss) on equity method investments   32,300   53,500      
Equity method investment, ownership (percent)           12.40%  
Market value of investment in Viking   $ 59,800   $ 59,800      
Outstanding warrants to purchase shares of Viking's common stock (shares)   1.5   1.5      
Warrant exercise price (USD per share)   $ 1.50   $ 1.50      
Recurring | Level 1 | Investment in Warrants              
Property, Plant and Equipment [Line Items]              
Assets, fair value   $ 12,300   $ 12,300     $ 3,800
Accounting Standards Update 2014-09 | Difference between Revenue Guidance in Effect before and after Topic 606              
Property, Plant and Equipment [Line Items]              
Total revenue   (10,400)   $ (1,500)      
Decrease in accumulated deficit $ 25,400            
Operating income (loss) (11,900)            
Accumulated Other Comprehensive Income | Accounting Standards Update 2016-01              
Property, Plant and Equipment [Line Items]              
Unrealized gain (loss) on equity method investments 2,600            
Retained Earnings | Accounting Standards Update 2016-01              
Property, Plant and Equipment [Line Items]              
Unrealized gain (loss) on equity method investments $ 2,600            
Royalty Agreements | Aziyo              
Property, Plant and Equipment [Line Items]              
Effective interest rate for forecasted cash flows (as a percent)       26.00%      
Royalty [Member]              
Property, Plant and Equipment [Line Items]              
Total revenue   31,396 14,211 $ 52,216 38,441    
Royalty [Member] | Calculated under Revenue Guidance in Effect before Topic 606              
Property, Plant and Equipment [Line Items]              
Total revenue   21,100 14,200   38,400    
Promacta              
Property, Plant and Equipment [Line Items]              
Total revenue   24,800   40,400      
Promacta | Calculated under Revenue Guidance in Effect before Topic 606              
Property, Plant and Equipment [Line Items]              
Total revenue   15,600 9,700   26,400    
Kyprolis              
Property, Plant and Equipment [Line Items]              
Total revenue   4,700   8,100      
Kyprolis | Calculated under Revenue Guidance in Effect before Topic 606              
Property, Plant and Equipment [Line Items]              
Total revenue   3,400 2,900   7,500    
Evomela              
Property, Plant and Equipment [Line Items]              
Total revenue   1,200   2,800      
Evomela | Calculated under Revenue Guidance in Effect before Topic 606              
Property, Plant and Equipment [Line Items]              
Total revenue   1,600 1,300   3,100    
Other              
Property, Plant and Equipment [Line Items]              
Total revenue   700   $ 900      
Other | Calculated under Revenue Guidance in Effect before Topic 606              
Property, Plant and Equipment [Line Items]              
Total revenue   $ 500 $ 300   $ 1,400